Bladder cancer course, four genetic high-risk variants, and histopathological findings
EXCLI Journal · 18.08.2023 · 22 · 867-879
DOI: 10.17179/excli2023-5862 ↗Kurz gefasst
Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 18.08.2023. Verfasst von Thura Kadhum und 13 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Urinary bladder cancer, a smoking and occupation related disease, was subject of several genome-wide association studies (GWAS). However, studies on the course of the disease based on GWAS findings differentiating between muscle invasive bladder cancer (MIBC) and non-muscle invasive bladder cancer (NMIBC) are rare. Thus we investigated 4 single nucleotide polymorphisms (SNPs) detected in GWAS, related to the genes coding for TACC3 (transforming, acidic coiled-coil containing protein 3), for FGFR3 (fibroblast growth factor receptor 3), for PSCA (prostate stem cell antigen) and the genes coding for CBX6 (chromobox homolog 6) and APOBEC3A (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A). This study is based on 712 bladder cancer patients and 875 controls from 3 different case control studies in Germany. The 4 SNPs of interest (PSCA rs2294008 and rs2978974, FGFR3-TACC3 rs798766, and CBX6-APOBEC3A rs1014971) were determined by real-time polymerase chain reaction. The distribution of the 4 SNPs does not vary significantly between cases and controls in the entire study group and in the 3 local subgroups, including two former highly industrialized areas and a region without such history. Also, no significant differences in the bladder cancer subgroups of MIBC and NMIBC were observed. The 4 investigated SNPs do not noticeably contribute differently to the bladder cancer risk for the bladder cancer subgroups of MIBC and NMIBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany.
- Specialist Clinic for Psychosomatic Rehabilitation, Mittelrhein-Klinik, Boppard - Bad Salzig, Germany.
- Department of Urology, Evangelic Hospital, Paul-Gerhardt Foundation, Lutherstadt Wittenberg, Germany.
- St.-Josefs-Hospital Dortmund-Hoerde, Dortmund, Germany.
- Rheinland Klinikum Lukaskrankenhaus Neuss, Neuss, Germany.
Zitieren
APA
Kadhum, T., Selinski, S., Blaszkewicz, M., Reinders, J., Roth, E., Volkert, F., Ovsiannikov, D., Moormann, O., Gerullis, H., Barski, D., Otto, T., Höhne, S., Hengstler, J. G., & Golka, K. (2023). Bladder cancer course, four genetic high-risk variants, and histopathological findings. EXCLI Journal, 22, 867-879. https://doi.org/10.17179/excli2023-5862
Vancouver
Kadhum T, Selinski S, Blaszkewicz M, Reinders J, Roth E, Volkert F, et al. Bladder cancer course, four genetic high-risk variants, and histopathological findings. EXCLI Journal. 2023;22:867-879. doi:10.17179/excli2023-5862
BibTeX
@article{Kadhum2023,
author = {Kadhum, Thura and Selinski, Silvia and Blaszkewicz, Meinolf and Reinders, Jörg and Roth, Emanuel and Volkert, Frank and Ovsiannikov, Daniel and Moormann, Oliver and Gerullis, Holger and Barski, Dimitri and Otto, Thomas and Höhne, Svetlana and Hengstler, Jan G and Golka, Klaus},
title = {Bladder cancer course, four genetic high-risk variants, and histopathological findings},
journal = {EXCLI Journal},
year = {2023},
volume = {22},
pages = {867--879},
doi = {10.17179/excli2023-5862}
}
EUVIMED